哮喘联盟

   摘要
   综述目的: 本文的目的是为了强调突出坚持哮喘治疗依从性的现状及方法的艺术和当前的前景，文章从世界变态反应组织通过的“坚持治疗呼吸道过敏引发哮喘的治疗依从性宣言”，过敏性鼻炎及其对哮喘和全球过敏状况的影响，欧洲哮喘联盟和国际哮喘联盟几个方面进行综述。
   最新的研究发现: 我们目前已知哮喘药物治疗的依从性较低：约50％被开具需长期药物治疗的哮喘患者没有按照要求医嘱服用药物，至少部分的时间没有遵守医嘱。服用药物不依从性与哮喘控制差，不良的健康预后差及治疗成本增加有关。服用药物依从性不良差的原因是多方面的，可能原因有与患者本身、治疗方式、和哮喘的特点、医患关系及医疗资源和设施有关。
   总结: 考虑到药物依从性的多面性，不是单一的干预或策略能够提升哮喘药物治疗的依从性。但是，参与这一进程的所有成员（政府部门、患者组织、科学团体研机构、利益相关者和其他人）应携手合作，创造一种基于患者复杂性的联组行动计划。
 

（苏欣 审校）
Curr Opin Allergy Clin Immunol. 2014 Dec 4. [Epub ahead of print]

 

Adherence to asthma treatments: 'we know, we intend, we advocate'
 

Braido F1, Baiardini I, Blasi F, Pawankar R, Canonica GW.
 

Abstract
PURPOSE OF THE REVIEW: To highlight the state of the art and the current outlook on the adherence to treatment in asthma, starting from the 'Manifesto on Adherence to asthma treatment in respiratory allergy' endorsed by the World Allergy Organization, Allergic Rhinitis and Its Impact on Asthma and Global Allergy, Asthma European Network, and Interasma.
RECENT FINDINGS: Adherence to the pharmacological treatments of asthma is known to be low: about 50% of those who had been prescribed long-term treatment are nonadherent, at least part of the time. Nonadherence is associated with lack of asthma control, poor health outcomes, and increased costs. The reasons for suboptimal adherence are multifaceted and may be related to the patients, the treatment and asthma features, the physician-patient relationship, and the healthcare resources and facilities.
SUMMARY: Taking into account the multidimensional nature of adherence, no single intervention or strategy is per se able to enhance it, but all players involved in the process (government authorities, patient organizations, scientific societies, stakeholders, and others) are called to work together to develop a combined action plan based on the patient's complexity.
 

Curr Opin Allergy Clin Immunol. 2014 Dec 4. [Epub ahead of print]